Article Versions Notes

Kalicińska E, Szymczak D, Zińczuk A, Adamik B, Smiechowicz J, Skalec T, Nowicka-Suszko D, Biernat M, Bogucka-Fedorczuk A, Rybka J, et al. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study. Cells. 2021; 10(6):1293. https://doi.org/10.3390/cells10061293

Kalicińska, Elżbieta, Donata Szymczak, Aleksander Zińczuk, Barbara Adamik, Jakub Smiechowicz, Tomasz Skalec, Danuta Nowicka-Suszko, Monika Biernat, Aleksandra Bogucka-Fedorczuk, Justyna Rybka, and et al. 2021. "Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study" Cells 10, no. 6: 1293. https://doi.org/10.3390/cells10061293

Kalicińska, E., Szymczak, D., Zińczuk, A., Adamik, B., Smiechowicz, J., Skalec, T., Nowicka-Suszko, D., Biernat, M., Bogucka-Fedorczuk, A., Rybka, J., Martuszewski, A., Gozdzik, W., Simon, K., & Wróbel, T. (2021). Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study. Cells, 10(6), 1293. https://doi.org/10.3390/cells10061293